Skip to Content
Merck
CN

228818

Diethyl propylmalonate

99%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
CH3CH2CH2CH(COOC2H5)2
CAS Number:
Molecular Weight:
202.25
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
218-492-2
Beilstein/REAXYS Number:
510157
MDL number:
Assay:
99%
Form:
liquid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

99%

form

liquid

refractive index

n20/D 1.418 (lit.)

bp

221-222 °C (lit.)

density

0.987 g/mL at 25 °C (lit.)

SMILES string

CCCC(C(=O)OCC)C(=O)OCC

InChI

1S/C10H18O4/c1-4-7-8(9(11)13-5-2)10(12)14-6-3/h8H,4-7H2,1-3H3

InChI key

GRRSDGHTSMJICM-UHFFFAOYSA-N

Application

Diethyl propylmalonate was used in the synthesis of propylacrylic acid (PAA).


Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

197.6 °F - closed cup

flash_point_c

92 °C - closed cup

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Mohamed E H El-Sayed et al.
Journal of controlled release : official journal of the Controlled Release Society, 104(2), 417-427 (2005-06-29)
Limited cytoplasmic delivery of enzyme-susceptible drugs remains a significant challenge facing the development of protein and nucleic acid therapies that act in intracellular compartments. "Smart" pH-responsive, membrane-destabilizing polymers present a new approach to shuttling therapeutic molecules past the endosomal membrane
Kyle M Hocking et al.
Tissue engineering. Part A, 25(5-6), 416-426 (2018-08-23)
Subarachnoid hemorrhage (SAH) is associated with vasospasm that is refractory to traditional vasodilators, and inhibition of vasospasm after SAH remains a large unmet clinical need. SAH causes changes in the phosphorylation state of the small heat shock proteins (HSPs), HSP20
Feng Qiu et al.
Biomaterials, 182, 82-91 (2018-08-15)
Cancer vaccines targeting patient-specific tumor neoantigens have recently emerged as a promising component of the rapidly expanding immunotherapeutic armamentarium. However, neoantigenic peptides typically elicit weak CD8+ T cell responses, and so there is a need for universally applicable vaccine delivery



Global Trade Item Number

SKUGTIN
228818-5G04061838781505